Effect of Tocilizumab on LDL and HDL Characteristics in Patients with Rheumatoid Arthritis. An Observational Study

BACKGROUND: In patients with rheumatoid arthritis (RA), qualitative alterations of low and high-density lipoproteins (LDL and HDL, respectively) might partially explain their increased cardiovascular risk. Tocilizumab has been associated with an increase in lipids, including triglyceride (TG) and ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Pierini, Florencia S., Botta, Eliana, Soriano, Enrique R., Martin, Maximiliano, Boero, Laura, Meroño, Tomás, Saez, María Soledad, Lozano Chiappe, Ezequiel, Cerda, Osvaldo, Citera, Gustavo, Gandino, Ignacio, Rosa, Javier, Sorroche, Patricia, Kontush, Anatol, Brites, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217399/
https://www.ncbi.nlm.nih.gov/pubmed/33811316
http://dx.doi.org/10.1007/s40744-021-00304-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217399/
https://www.ncbi.nlm.nih.gov/pubmed/33811316
http://dx.doi.org/10.1007/s40744-021-00304-0

Ejemplares similares